Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
40.89
-0.56 (-1.35%)
May 20, 2026, 11:29 AM CST

SHA:600211 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,19413,71511,90612,0998,90612,982
Market Cap Growth
11.18%15.19%-1.59%35.86%-31.40%-22.18%
Enterprise Value
10,76011,8019,88010,3697,66212,467
Last Close Price
41.4542.5535.2934.3324.3835.22
PE Ratio
13.8214.6211.3315.1124.0862.13
Forward PE
-26.4826.4826.4826.4826.48
PS Ratio
4.414.604.243.863.496.07
PB Ratio
3.123.323.013.592.944.91
P/TBV Ratio
3.744.023.203.863.445.88
P/FCF Ratio
12.4013.8712.4411.6212.11-
P/OCF Ratio
12.2413.6511.9711.3810.6435.42
EV/Sales Ratio
3.603.963.523.313.005.83
EV/EBITDA Ratio
11.2211.7810.209.3710.1219.06
EV/EBIT Ratio
12.2312.7611.069.9811.1321.77
EV/FCF Ratio
10.1111.9310.329.9510.42-
Debt / Equity Ratio
0.250.200.070.150.160.20
Debt / EBITDA Ratio
1.010.840.280.450.640.82
Debt / FCF Ratio
1.000.850.290.480.66-
Net Debt / Equity Ratio
-0.65-0.63-0.59-0.56-0.48-0.29
Net Debt / EBITDA Ratio
-2.62-2.60-2.43-1.69-1.91-1.17
Net Debt / FCF Ratio
-2.60-2.64-2.46-1.80-1.9612.93
Asset Turnover
0.520.540.600.720.650.63
Inventory Turnover
1.091.091.321.501.732.17
Quick Ratio
2.732.674.402.742.511.76
Current Ratio
2.882.834.662.872.641.97
Return on Equity (ROE)
22.23%22.67%28.86%25.30%13.23%8.14%
Return on Assets (ROA)
10.49%10.49%11.96%14.95%10.89%10.61%
Return on Invested Capital (ROIC)
57.32%52.08%52.87%60.70%32.15%25.90%
Return on Capital Employed (ROCE)
20.60%20.00%22.40%30.50%22.40%21.30%
Earnings Yield
7.33%6.84%8.83%6.62%4.15%1.61%
FCF Yield
8.06%7.21%8.04%8.61%8.26%-0.46%
Dividend Yield
4.24%4.13%5.55%4.34%2.35%0.74%
Payout Ratio
54.67%65.41%47.95%61.74%26.55%63.41%
Buyback Yield / Dilution
-0.15%0.05%0.14%-0.09%0.21%-0.53%
Total Shareholder Return
4.11%4.18%5.69%4.26%2.56%0.20%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.